Does Iron Supplements Interact with Technetium Tc 99m Oxidronate?
CDI records a moderate classification for Iron Supplements and Technetium Tc 99m Oxidronate. The stored summary is: High levels of iron may alter biodistribution of technetium Tc 99m oxidronate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality. The mechanism involves high levels of iron cations alter radionuclide biodistribution. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
High levels of iron cations alter radionuclide biodistribution
What To Tell Your Doctor or Pharmacist
If you are taking Iron Supplements and your doctor is considering prescribing Technetium Tc 99m Oxidronate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider